Top

Published in:

01-03-2015

Definition of Barrett’s Esophagus Dysplasia: Are We Speaking the Same Language?

Authors: Massimo Rugge, Marco Pizzi, Carlo Castoro

Published in: World Journal of Surgery | Issue 3/2015

Abstract

The definition of Barrett’s esophagus (BE) is still a matter of debate. The diagnostic criteria adopted around the world for both BE and BE-related pre-cancerous lesions are inconsistent, particularly between Eastern and Western pathologists. From a clinical perspective, these different clinico-biological approaches may affect how the literature is interpreted, with detrimental effects on the clinical management of patients. The present review focuses on the major discrepancies in the field, covering both the non-neoplastic and the pre-cancerous lesions associated with Barrett’s disease.

Descartes R (1998) Discourse on method and meditations on first philosophy. Hackett Publishing Company, Indianapolis

Barrett NR (1950) Chronic peptic ulcer of the oesophagus and “oesophagitis”. Br J Surg 38:175–182CrossRefPubMed

Riddell RH, Odze RD (2009) Definition of Barrett’s esophagus: time for a rethink—is intestinal metaplasia dead? Am J Gastroenterol 104(10):2588–2594CrossRefPubMed

de Jonge PJ, van Blankenstein M, Grady WM et al (2014) Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut 63(1):191–202CrossRefPubMed

Takubo K, Arai T, Sawabe M et al (2003) Structures of the normal esophagus and Barrett’s esophagus. Esophagus 1:37–47CrossRef

Hvid-Jensen F, Pedersen L, Drewes AM et al (2011) Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 365:1375–1383CrossRefPubMed

Rugge M, Capelle LG, Cappellesso R et al (2013) Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol 27(2):205–223CrossRefPubMed

Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: parts II and III. Esophagus 6:71–94CrossRef

Fitzgerald RC, di Pietro M, Ragunath K et al (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 63(1):7–42CrossRefPubMed

10.

Jass JR (2000) Discrepancies between East and West. Cancer 88(5):969–970CrossRefPubMed

11.

Mueller J, Werner M, Stolte M (2004) Barrett’s esophagus: histopathologic definitions and diagnostic criteria. World J Surg 28(2):148–154. doi:10.1007/s00268-003-7050-4 CrossRefPubMed

12.

Paull A, Trier JS, Dalton MD et al (1976) The histologic spectrum of Barrett’s esophagus. N Engl J Med 295:476–480CrossRefPubMed

13.

Fiocca R, Mastracci L, Milione M et al (2011) Microscopic esophagitis and Barrett’s esophagus: the histology report. Dig Liver Dis 43(Suppl 4):S319–S330CrossRefPubMed

14.

Takubo K, Vieth M, Aida J et al (2009) Differences in the definitions used for esophageal and gastric diseases in different countries: endoscopic definition of the esophagogastric junction, the precursor of Barrett’s adenocarcinoma, the definition of Barrett’s esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion 80(4):248–257CrossRefPubMed

15.

Sharma P, Dent J, Armstrong D et al (2006) The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131(5):1392–1399CrossRefPubMed

16.

Spechler SJ, Sharma P, Souza RF et al (2011) American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology 140:e18–e52CrossRefPubMedCentralPubMed

17.

Amano Y, Ishimura N, Furuta K et al (2006) Which landmark results in a more consistent diagnosis of Barrett’s esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc 64:206–211CrossRefPubMed

18.

Rugge M, Fassan M, Battaglia G et al (2009) Intestinal or gastric? The unsolved dilemma of Barrett’s metaplasia. Hum Pathol 40(8):1206–1207CrossRefPubMed

19.

Smith RR, Hamilton SR, Boitnott JK et al (1984) The spectrum of carcinoma arising in Barrett’s esophagus. A clinicopathologic study of 26 patients. Am J Surg Pathol 8:563–573CrossRefPubMed

20.

Bhat S, Coleman HG, Yousef F et al (2011) Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049–1057CrossRefPubMedCentralPubMed

21.

Spechler SJ, Sharma P, Souza RF et al (2011) American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140(3):1084–1091CrossRefPubMed

22.

Vakil N, van Zanten SV, Kahrilas P et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8):1900–1920CrossRefPubMed

23.

Jankowski JA, Harrison RF, Perry I et al (2000) Barrett’s metaplasia. Lancet 356(9247):2079–2085CrossRefPubMed

24.

Kelty CJ, Gough MD, Van Wyk Q et al (2007) Barrett’s oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol 42(11):1271–1274CrossRefPubMed

25.

Takubo K, Aida J, Naomoto Y et al (2009) Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 40:65–74CrossRefPubMed

26.

Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: part I. Esophagus 6:1–25CrossRef

27.

Hahn HP, Blount PL, Ayub K et al (2009) Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol 33(7):1006–1015CrossRefPubMedCentralPubMed

28.

Fassan M, Volinia S, Palatini J et al (2013) MicroRNA expression profiling in the histological subtypes of Barrett’s metaplasia. Clin Transl Gastroenterol 4:e34CrossRefPubMedCentralPubMed

29.

Oryu M, Mori H, Kobara H et al (2013) Differences in the characteristics of Barrett’s esophagus and Barrett’s adenocarcinoma between the United States and Japan. ISRN Gastroenterol 2013:840690CrossRefPubMedCentralPubMed

30.

Odze RD, Riddell RH, Bosman FT et al (2010) Premalignant lesions of the digestive system. In: Bosman FT, Carneiro F, Hruban RH et al (eds) WHO classification of tumours of the digestive system. IARC, Lyon, pp 10–12

31.

Schlemper RJ, Itabashi M, Kato Y et al (1997) Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 349(9067):1725–1729CrossRefPubMed

32.

Takubo K, Arai T, Ishiguro S (2002) Patient presentation and pathologic diagnosis of superficial carcinoma of the esophagus: high-grade dysplasia and mucosal carcinoma from the Japanese standpoint. In: Imamura M (ed) Superficial esophageal neoplasm: pathology, diagnosis, and therapy. Springer, Tokyo, pp 141–147CrossRef

33.

Rugge M, Correa P, Dixon MF et al (2000) Gastric dysplasia: the Padova international classification. Am J Surg Pathol 24(2):167–176CrossRefPubMed

34.

Fassan M, Pizzi M, Farinati F et al (2012) Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. Am J Clin Pathol 137:727–732CrossRefPubMed

35.

Japanese Gastric Cancer Association (2011) Japanese classification of esophageal cancer, tenth edition: part I. Gastric Cancer 14:101–112CrossRef

36.

Schlemper RJ, Riddell RH, Kato Y et al (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47:251–255CrossRefPubMedCentralPubMed

37.

Dixon MF (2002) Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 51(1):130–131CrossRefPubMedCentralPubMed

38.

Dobbins W (1966) The intestinal mucosal lymphatic in man. A light and electron microscopic study. Gastroenterol 51(6):994–1003

39.

Akashi Y, Noguchi T, Nagai K et al (2011) Cytoarchitecture of the lamina muscularis mucosae and distribution of the lymphatic vessels in the human stomach. Med Mol Morphol 44(1):39–45CrossRefPubMed

40.

Flejou JF, Odze RD, Montgomery E et al (2010) Adenocarcinoma of the oesophagus. In: Bosman FT, Carneiro F, Hruban RH et al (eds) WHO classification of tumours of the digestive system. IARC, Lyon, pp 27–28

41.

Fassan M, Baffa R, Kiss A et al (2013) MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. Curr Pharm Des 19(7):1236–1241

42.

Pizzi M, Fassan M, Realdon S et al (2012) Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma. Hum Pathol 43(11):1839–1844

Title: Definition of Barrett’s Esophagus Dysplasia: Are We Speaking the Same Language?
Authors: Massimo Rugge
Marco Pizzi
Carlo Castoro
Publication date: 01-03-2015
Publisher: Springer US
Published in: World Journal of Surgery / Issue 3/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-014-2692-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Definition of Barrett’s Esophagus Dysplasia: Are We Speaking the Same Language?

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

Large Standard Deviation: Think Before You Write

Antireflux Surgery for Dysplastic Barrett’s Esophagus

Patients Recovering From Abdominal Surgery Who Walked With Volunteers Exhibited Improved Postoperative Recovery Profiles During Hospitalization

Pedestrian Injuries-Related Deaths: A Global Evaluation

Surgical Treatment of Incidental Gallbladder Cancer Discovered During or Following Laparoscopic Cholecystectomy

Minimally Invasive Esophagectomy for Dysplastic Barrett’s Esophagus